FDA Revokes Emergency Use Authorization for Gilead's Remdesivir

Summary

The FDA has revoked the Emergency Use Authorization for Gilead's VEKLURY (remdesivir) due to the approval of a supplemental new drug application, expanding the approved indication to cover the authorized population.